Skip to content
About Inovarion
Our expertise
Therapeutic areas
Experimental approaches
Close the menu
Therapeutic areas
All therapeutic areas
Oncology
Cardiovascular Diseases
Neurology
Infectious Diseases
Immunology
Metabolic Diseases
Vaccinology
Hematology
Rare Diseases
Experimental approaches
All experimental approaches
Cellular Biology
Molecular Biology
Bioinformatics
Biochemistry
Imaging
In vivo & preclinical models
Clinical & translational research
Our publications
Join us
Contact us
en
en
de
fr
Menu
About Inovarion
Our expertise
Therapeutic areas
Experimental approaches
Close the menu
Therapeutic areas
All therapeutic areas
Oncology
Cardiovascular Diseases
Neurology
Infectious Diseases
Immunology
Metabolic Diseases
Vaccinology
Hematology
Rare Diseases
Experimental approaches
All experimental approaches
Cellular Biology
Molecular Biology
Bioinformatics
Biochemistry
Imaging
In vivo & preclinical models
Clinical & translational research
Our publications
Join us
Contact us
en
en
de
fr
Targeting AU-rich element-mediated mRNA decay with a truncated active form of the zinc-finger protein TIS11b/BRF1 impairs major hallmarks of mammary tumorigenesis
Read the original article
Search for:
>